T. Rowe Price Investment Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
T. Rowe Price Investment Management's RGEN Position: Q2 2026 in Review
T. Rowe Price Investment Management increased its Repligen (RGEN) stake by 3.3% in Q2 2026, buying an estimated $5.52M and bringing the position to 1,411,619 shares worth $193M. The position accounts for 0.13% of the portfolio, ranked #184.
T. Rowe Price Investment Management first reported a position in RGEN in Q3 2022 and has held it in 16 quarters since. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- T. Rowe Price Investment Management held 1,411,619 shares of Repligen worth $193M as of Q2 2026.
- T. Rowe Price Investment Management bought 44,939 Repligen shares in Q2 2026, an estimated $5.52M.
- Repligen made up 0.13% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #184 holding.
- T. Rowe Price Investment Management first reported a position in Repligen in Q3 2022 and has held it in 16 quarters since.
- 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.